
The Australian | LTR Pharma completes study milestone for SPONTAN® ED treatment
The Australian has published a Special Report titled ‘LTR Pharma completes study milestone for SPONTAN ED treatment’, outlining that LTR Pharma has completed a key extractables study for its SPONTAN intranasal spray for erectile dysfunction and kicked off a leachables study as part of a regulatory development program. “The completion